Abstract
Studying consanguineous families with Ghosal hematodiaphyseal dysplasia syndrome (GHDD), a disorder of increased bone density, we identified mutations in TBXAS1, which encodes thromboxane synthase (TXAS). TXAS, an enzyme of the arachidonic acid cascade, produces thromboxane A2 (TXA2). Platelets from subjects with GHDD showed a specific deficit in arachidonic acid-produced aggregation. We also found that TXAS and TXA2 modulated expression of TNFSF11 and TNFRSF11B (encoding RANKL and osteoprotegerin (OPG), respectively) in primary cultured osteoblasts. © 2008 Nature Publishing Group.
Cite
CITATION STYLE
Geneviève, D., Proulle, V., Isidor, B., Bellais, S., Serre, V., Djouadi, F., … Cormier-Daire, V. (2008). Thromboxane synthase mutations in an increased bone density disorder (Ghosal syndrome). Nature Genetics, 40(3), 284–286. https://doi.org/10.1038/ng.2007.66
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.